Skip to main content

Table 2 Baseline patients characteristics, n (%) or mean ± standard deviation (SD) or median (25th–75th)

From: Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China

 

HD

PD

KT (first year)

KT (second year)

No. Patients

3765

1237

117

41

Gender: Male

2089(55.5)

683(55.2)

82(70.1)

31(75.6)

Age (years)

 Mean ± SD

57.5 ± 15.8

51.1 ± 16.1

37.0 ± 9.7

39.0 ± 11.2

Age Group

 18–45 years

827(22.0)

472(38.2)

93(79.5)

29(70.7)

 45–60 years

1166(31.0)

357(28.9)

23(19.7)

11(26.8)

 60–75 years

1168(31.0)

305(24.7)

1(0.9)

1(2.4)

  ≥ 75 years

604(16.0)

103(8.3)

0(0.0)

0(0.0)

Comorbidities

 None

1520(40.4)

703(56.8)

77(65.8)

28(68.3)

 Hypertension

2042(54.2)

468(37.8)

38(32.5)

12(29.3)

 Diabetes

1057(28.1)

271(21.9)

7(6.0)

4(9.8)

 Coronary

362(9.6)

52(4.2)

2(1.7)

0(0.0)

Insurance type

 UEBMI

3341(88.7)

1137(91.9)

117(100.0)

41(100.0)

 URBMI

424(11.3)

100(8.1)

0(0.0)

0(0.0)

  1. HD Haemodialysis, PD Peritoneal Dialysis, KT Kidney Transplantation, UEBMI Urban Employee-based Basic Medical Insurance scheme, URBMI Urban Resident-based Basic Medical Insurance scheme